Qingdao Haier Biomedical Co Ltd
SSE:688139

Watchlist Manager
Qingdao Haier Biomedical Co Ltd Logo
Qingdao Haier Biomedical Co Ltd
SSE:688139
Watchlist
Price: 33.25 CNY 0.09% Market Closed
Market Cap: ¥10.5B

Wall Street
Price Targets

Price Targets Summary
Qingdao Haier Biomedical Co Ltd

There are no price targets for Qingdao Haier Biomedical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Qingdao Haier Biomedical Co Ltd Competitors:
Price Targets
PMT
PennyMac Mortgage Investment Trust
11% Upside
TEL
TE Connectivity Ltd
15% Upside
UMBF
UMB Financial Corp
22% Upside
XO
Exotic Food PCL
30% Upside

Revenue
Forecast

20% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
20% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 7 years the compound annual growth rate for Qingdao Haier Biomedical Co Ltd's revenue is 20%. The projected CAGR for the next 3 years is 12%.

Operating Income
Forecast

27% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
27% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

For the last 7 years the compound annual growth rate for Qingdao Haier Biomedical Co Ltd's operating income is 27%. The projected CAGR for the next 3 years is 25%.

Net Income
Forecast

29% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
29% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 7 years the compound annual growth rate for Qingdao Haier Biomedical Co Ltd's net income is 29%. The projected CAGR for the next 3 years is 6%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Qingdao Haier Biomedical Co Ltd's stock price target?
Not Available

Qingdao Haier Biomedical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Qingdao Haier Biomedical Co Ltd's Revenue forecast?
Projected CAGR
12%

For the last 7 years the compound annual growth rate for Qingdao Haier Biomedical Co Ltd's revenue is 20%. The projected CAGR for the next 3 years is 12%.

What is Qingdao Haier Biomedical Co Ltd's Operating Income forecast?
Projected CAGR
25%

For the last 7 years the compound annual growth rate for Qingdao Haier Biomedical Co Ltd's operating income is 27%. The projected CAGR for the next 3 years is 25%.

What is Qingdao Haier Biomedical Co Ltd's Net Income forecast?
Projected CAGR
6%

For the last 7 years the compound annual growth rate for Qingdao Haier Biomedical Co Ltd's net income is 29%. The projected CAGR for the next 3 years is 6%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett